Thomas Ebeling

Thomas Ebeling

Director/Board Member bij CULLINAN THERAPEUTICS, INC.

Vermogen: 1 M $ op 31-03-2024

65 jaar
Health Technology
Finance
Consumer Services

Profiel

Thomas Ebeling is the founder of Betterlifehealthcare Ltd.
(founded in 2015), Heilpflanzenwohl AG (founded in 2016), and Te Convest AG (founded in 2018).
He is currently the Chairman of the Fund at Remagine Media Ventures, Chairman at Galderma Group AG, Director at Sivantos, Inc. (Canada), Director at Galderma Holding SA, Director at ClearVAT AG, Director at Triangle Holding III SARL, Director at SHL Medical AG, Director at Orna Therapeutics, Inc. (since 2022), Independent Director at Cullinan Oncology, Inc. (since 2017), Advisor at MPM BioImpact, Inc, Member-Supervisory Board at Schwandorfer Rohstoff- und Recycling GmbH, and Board Member & Strategic Advisor at Moonfare GmbH (since 2018).
His former positions include Chairman-Executive Board & CEO at ProSiebenSat.1 Media SE (2009-2017), Chief Executive Officer-Pharmaceuticals Division at Novartis AG (2000-2007), Chief Executive Officer at Novartis Pharmaceuticals Corp.
(2000-2007), Chief Executive Officer at Novartis Consumer Health, Inc. (2007-2008), Chief Executive Officer at Novartis Nutrition GmbH (1998-2000), Chairman at Auris Luxembourg III SA, Chairman-Supervisory Board at Apleona GmbH, Chairman-Supervisory Board at Ostbayerische Verwertungs- und Energieerzeugungsgesellschaft, Director at Idenix Pharmaceuticals LLC, Independent Director at Lonza Group AG (2013-2017), Director-National Sales & Franchise at PepsiCo Deutschland GmbH (1994-1996), Director at EQT AB, Independent Non-Executive Director at Ocean Outdoor Ltd.
(2018-2021), Independent Director at Cullinan Oncology LLC, Member-Supervisory Board at QIAGEN NV, and Member-Supervisory Board at Bayer AG (2012-2019).
He holds an undergraduate degree from the University of Hamburg (1986).

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-02-2024 67 504 ( 0.16% ) 1 M $ 31-03-2024
28-02-2023 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Thomas Ebeling

BedrijvenFunctieBegin
CULLINAN THERAPEUTICS, INC. Director/Board Member 01-08-2017
Remagine Media Ventures/Germany/ Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 09-03-2022
Consultant / Advisor -
Director/Board Member -
Director/Board Member 01-01-2016
Triangle Holding III SARL Director/Board Member -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle actieve functies van Thomas Ebeling

Eerdere bekende functies van Thomas Ebeling

BedrijvenFunctieEinde
░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Ervaring van Thomas Ebeling in detail bekijken

Opleiding van Thomas Ebeling

University of Hamburg Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Thomas Ebeling in detail bekijken

Connecties

100 +

Eerstegraads connecties

32

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven7
QIAGEN N.V.

Health Technology

BAYER AG

Health Technology

PROSIEBENSAT.1 MEDIA SE

Consumer Services

NOVARTIS AG

Health Technology

LONZA GROUP AG

Health Technology

EQT AB

Finance

CULLINAN THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit24

Health Technology

Finance

Consumer Non-Durables

Health Technology

Health Technology

Consumer Non-Durables

Retail Trade

Health Technology

Finance

Commercial Services

Commercial Services

Finance

Finance

Industrial Services

Transportation

Heilpflanzenwohl AG

Te Convest AG

Finance

Triangle Holding III SARL

Health Technology

Health Technology

Remagine Media Ventures/Germany/

Finance

Novartis Nutrition GmbH

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Thomas Ebeling